As part of The Wistar Institute’s Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...

Breast cancer is the world's most prevalent cancer. Although earlier detection and targeted treatment have resulted in high survival rates, many breast cancer survivors experience fear of cancer ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

According to a study published in Advanced Functional Materials on November 24th, 2024, a group of researchers led by ...

By integrating these strategies, it concluded, the Nigerian government can create a comprehensive framework that reduces ...

FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...

A new hope for those battling cancer is on the horizon as Lubbock takes a few more steps closer to becoming a cancer research and treatment ... The National Cancer Institute designation is given ...

WASHINGTON, DC, UNITED STATES, January 28, 2025 /EINPresswire / -- The National Cancer Treatment Alliance (NCTA) , a national Network of independent community oncology practices that works with ...

Antonina Mitrofanova, an associate professor in the Department of Health Informatics and associate dean for research at the ...

A novel AI tool from BIFOLD and partner institutions deciphers complex cancer interrelationships, enhancing personalized ...

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders – T cells – lose their ability to function effectively.

“Mutations are very important — but they’re not the entire explanation for a tumor,” said Douglas Hanahan, a distinguished scholar at the Ludwig Institute ... national cancer research and ...